// App-Quantinova.ai

: Clinical Outcomes of Chronic Myeloid Leukaemia (CML) Patients on Asciminib through the Managed Access Program (MAP) in Australia

Researchers

Presenter

  • Lynette C.Y. Chee

Principal Investigators

  • Nora Lee

  • Andrew Grigg

  • Melissa Chen

  • Anthony Schwarer

  • Jeff Szer

  • David T Yeung

  • Timothy Hughes

  • Naranie Shanmuganathan

Medical Centers

  • Department of Haematology, Box Hill Hospital, Box Hill, Australia

  • Monash Haematology, Monash Health, Clayton, Australia

  • Bendigo Cancer Centre, Bendigo Hospital, Bendigo, Australia

  • Department of Clinical Haematology, Austin Health, Heidelberg, Australia

  • Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia

  • School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia

  • Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia

  • Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, Australia

  • South Australian Health and Medical Research Institute SAHMRI, Adelaide, Australia

  • Department of Medicine, The University of Melbourne, Parkville, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

Biomarkers

  • Abelson murine leukemia viral oncogene homolog

  • Breakpoint Cluster Region

Drug/Treatment

  • ABL001

Outcome

  • N/A

Study Design

  • Efficacy

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved